Sarcoma News

Long-term exposure to ambient fine particulate matter significantly increased risk for cancer mortality among elderly people in Hong Kong, according to study results.

Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a cross-sectional study published in JAMA Oncology.

Approximately one in 12 patients with a common primary tumor were diagnosed with a second primary malignancy between 1992 and 2008, according to results of a SEER analysis.

Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a randomized observational study.

An estimated 12,310 people in the United States will be diagnosed with soft tissue sarcomas this year, and 4,990 Americans will die of the disease, according to the American Cancer Society.

Underrepresentation of Hispanic patients and children aged 0 to 4 years occurred frequently in phase 1 trials, according to a meta-analysis of trials conducted by Children’s Oncology Group and Pediatric Brain Cancer Consortium.

Pediatric and young adult patients with recurrent or refractory osteosarcoma demonstrated uniformly poor EFS outcomes, according to a retrospective analysis of seven phase 2 trials.

The FDA granted breakthrough therapy designation to LOXO-101 for the treatment of unresectable or metastatic solid tumors with neurotrophic tyrosine receptor kinase gene fusions, according to a press release from the agent’s manufacturer.

Memorial Sloan Kettering Cancer Center launched a new initiative designed to help teens and young adults with cancer.

The FDA today granted orphan drug designation to TK216 for the treatment of Ewing sarcoma, a rare pediatric cancer comprised of highly malignant, undifferentiated tumors of bone.